Search results

Guest

Guest

Create New Topic As guest or Sign in

HTML tags are not allowed

Assign topic to the user

  • Scope definition considering suppliers

    We received this question:

    >"If the client is allow to exclude the service provider or outsourcer from the scope since they do not have control over them, can they put a justification as such in the SOA to exclude the A15 control? The only concern we seen on some client, they will overlook the security matter related to services provider/outsourcer as to their understanding it has been excluded from the scope. How could we address such misunderstanding?

    Answer: Only because suppliers are excluded from the ISMS scope it doesn't mean controls from Annex A can be excluded from the SoA based on that. The scope definition and SoA elaboration are different processes that do not have this relationship.

    Considering that, a control can only be excluded from SoA if:
    - There are no law, contract or similar legal requirement demanding the control to be implemented, and
    - There are no unacceptable risks related to the outsourced service identified on risk assessments, or the organization consciously accepted the risks identified as unacceptable

    So, the fact that service providers or outsources are excluded from the ISMS scope is not the reason enough to justify excluding controls from section A.15. An organization has to evaluate first the legal requirements involved and the risks associated to the outsourced service.

    To handle this kind of misunderstanding, you can ask your clients this question: If you would consider security controls if you were running the service yourself, why do not require the same commitment from your suppliers?
  • Defining LOT number for medical device

    For the implants, yes it is necessary that the lot number must be on the device except the device is not too small. For all implants, there should be an implant card. According to the MDR 2017/745, Article 18. implant card must have the following information:

    • information allowing the identification of the device, including the device name, serial number, lot number, the UDI, the device model, as well as the name, address, and the website of the manufacturer
    • any warnings, precautions, or measures to be taken by the patient or a healthcare professional with regard to reciprocal interference with reasonably foreseeable external influences, medical examinations, or environmental conditions
    • any information about the expected lifetime of the device and any necessary follow-up
    • any other information to ensure the safe use of the device by the patient, including the information in point (u) of Section 23.4 of Annex I.
    For more information, see:
Page 845-vs-13485 of 1128 pages

Didn’t find an answer?

Start a new topic and get direct answers from the Expert Advice Community.

CREATE NEW TOPIC +